Blog

AI won't replace pathologists. But it will redefine what they do. Proscia CEO David West challenges the "replacement" narrative around AI in medicine — and makes the case that the real opportunity is using AI to eliminate administrative burden, not diagnostic expertise.

Precision medicine companies are processing unprecedented molecular volumes, serving distributed health system networks, and racing to deploy AI-driven diagnostics that can meaningfully improve patient outcomes. An enterprise pathology AI platform can transform fragmented workflows into a scalable, AI-ready engine for precision medicine growth.

Proscia has been named Global 2026 Best in KLAS for Digital Pathology in Europe and earned the top performance score in the U.S. in the 2026 KLAS Digital Pathology Report. Here’s why life sciences organizations should take notice.

Learn why Epic Beaker integration is now a strategic requirement (not a technical nice-to-have), what “Epic-native” digital pathology truly means in practice, and how leading AMCs are approaching integration to reduce risk, accelerate value, and prepare for AI-driven diagnostics.

The evolution of digital pathology, or whole slide imaging (WSI), has taken over 20 years. As AI-enabled digital pathology continue to advance, it will likely follow most technology curves; the costs will continue to come down and the variety of applications will increase.

Laboratories are increasingly turning to Laboratory Information System (LIS) integration to make their digital pathology world go around. This blog explores the importance of integrating LIS into digital pathology workflows, steps to ensure success, and how this integration can transform the field of pathology.

Learn how AWS enables Proscia to help their customers meet the unique demands of modern digital pathology - with a deeply integrated platform built from the ground up to take full advantage of the cloud.

As clinical adoption of digital pathology begins to catch up with its earlier momentum in the life sciences, laboratories are stepping into a new phase of economic opportunity. With a digital foundation in place, they’re beginning to unlock high-margin revenue streams by stepping into a broader role as partners in the precision medicine ecosystem.